Lista de obras - Brigitte Sigal-Zafrani - Dominio Público Uruguay

8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis

artículo científico publicado en 2009

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

artículo científico publicado en 2007

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics

artículo científico publicado en 2013

Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumors

artículo científico publicado en 2006

Benign breast diseases

artículo científico publicado en 2005

Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome

artículo científico publicado en 2012

Breast cancer survivors' perceived medical communication competence and satisfaction with care at the end of treatment

artículo científico publicado en 2015

Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization

artículo científico publicado en 2016

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance

artículo científico publicado en 2004

External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement

artículo científico publicado en 2011

Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations status

artículo científico publicado en 2009

Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas.

artículo científico publicado en 2015

Hormone replacement therapy after prophylactic adnexectomy

artículo científico publicado en 2005

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

artículo científico publicado en 2007

Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients

artículo científico publicado en 2011

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature

artículo científico publicado en 2009

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

artículo científico publicado en 2011

Large field, high resolution full-field optical coherence tomography: a pre-clinical study of human breast tissue and cancer assessment

artículo científico publicado en 2013

Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma

artículo científico publicado en 2013

Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomas

artículo científico publicado en 2013

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers

artículo científico publicado en 2017

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification

artículo científico publicado en 2012

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation

artículo científico publicado en 2012

Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma

scientific article (publication date: 2012)

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

artículo científico publicado en 2005

The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma

artículo científico publicado en 2011

Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment

artículo científico publicado en 2009

Visualizing Chromosomes as Transcriptome Correlation Maps: Evidence of Chromosomal Domains Containing Co-expressed Genes—A Study of 130 Invasive Ductal Breast Carcinomas

article

Lista de obras de Brigitte Sigal-Zafrani

8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics

Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumors

Benign breast diseases

Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome

Breast cancer survivors' perceived medical communication competence and satisfaction with care at the end of treatment

Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance

External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement

Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1/2 mutations status

Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas.

Hormone replacement therapy after prophylactic adnexectomy

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

Large field, high resolution full-field optical coherence tomography: a pre-clinical study of human breast tissue and cancer assessment

Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma

Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomas

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation

Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma

Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment

Visualizing Chromosomes as Transcriptome Correlation Maps: Evidence of Chromosomal Domains Containing Co-expressed Genes—A Study of 130 Invasive Ductal Breast Carcinomas